On average, analysts forecast that AADI's EPS will be -$ for , with the lowest EPS forecast at -$, and the highest EPS forecast at -$ On. Aadi Bioscience, Inc. (US:AADI) has institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Research Aadi Bioscience's (Nasdaq:AADI) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and. Aadi Bioscience Inc. ; Volume, K ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A. Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers.
Stock analysis for Aadi Bioscience Inc (AADI:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Get the latest Aadi Bioscience Inc (AADI) real-time quote, historical performance, charts, and other financial information to help you make more informed. Key Stats · Market CapM · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change Historical daily share price chart and data for Aadi Bioscience since adjusted for splits and dividends. The latest closing stock price for Aadi. Aadi Bioscience, a precision oncology company, announced Q1 financial results with FYARRO sales of $ million. The PRECISION1 trial is fully enrolled. Aadi Bioscience, Inc. (AADI) ; Aug 26, , , , , ; Aug 23, , , , , What was Aadi Bioscience's price range in the past 12 months? Aadi Bioscience lowest stock price was $ and its highest was $ in the past 12 months. Find the latest analyst research, reports, and ratings for Aadi Bioscience, Inc. Common Stock (AADI) at etoria.ru Overview - AADI ; M · K · -- · · No Dividend. Track Aadi Bioscience Inc (AADI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers.
Valuation: Aadi Bioscience, Inc. ; P/E ratio * · EV / Sales * · Yield *. AADI | Complete Aadi Bioscience Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Aadi Bioscience, Inc.'s latest quarterly earnings per share is $ with a past EPS surprise of $ The latest EPS estimate is $ Read more about Aadi. Buying or selling a stock that's not traded in your local currency? Don't let the currency conversion trip you up. Convert Aadi Bioscience Inc stocks or shares. Discover real-time Aadi Bioscience, Inc. Common Stock (AADI) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with. The current price of AADI is USD — it hasn't changed in the past 24 hours. Watch Aadi Bioscience, Inc. stock price performance more closely on the chart. In the current month, AADI has received 3 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. AADI average Analyst price target in the past 3 months is $ Jul PM · Aadi Bioscience to Report Second Quarter Results and Corporate Update. (PR Newswire) ; Jul PM · 3 Russell Stocks to Sell.
Aadi Bioscience, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on developing and commercializing precision therapies for cancers. At Aadi Bioscience, our mission is to improve the lives of people with mTOR-driven diseases. We believe success depends on addressing the limitations of current. On Tuesday 08/13/ the closing price of the Aadi Bioscience Inc Registered Shs share was $ on BTT. Compared to the opening price on Tuesday 08/13/ on. Aadi Bioscience has a consensus price target of $ Q. What is the current price for Aadi Bioscience (AADI)?. A. The stock. View the AADI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aadi Bioscience Inc.
Growth stocks won't see vast outperformance with slowing economy, says Trivariate's Parker
Analyst's Opinion · Consensus Rating. Aadi Bioscience has received a consensus rating of Hold. · Amount of Analyst Coverage. Aadi Bioscience has been the. Is Aadi Bioscience, Inc. stock A Buy? Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level.